ALK and lung carcinoma: The EML4-ALK fusion, initially identified in lung cancer [9, 10] has since been reported in breast cancer [124], colorectal carcinomas [66, 124], and in pediatric renal medullary carcinoma that affects young African–Americans with the sickle cell trait [125, 126].